Heart Failure Crisis Registry Study
Part of Heart & circulation clinical trials.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to University Hospital Basel with cardiogenic shock, or develop it during your hospital stay
- You are 18 years old or older
- Your heart is not pumping blood effectively, causing low oxygen and nutrients to reach your organs
- Your blood pressure is very low (below 90 mmHg) or you need medications/machines to support your circulation
- Blood tests show signs your body is not getting enough oxygen (high lactate levels)
- You have at least one sign of poor circulation, such as cold extremities, confusion, low urine output, or fluid buildup
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from adults who need a temporary heart circulation support device such as VA-ECMO or an Impella pump (or newer similar devices). It may help doctors better understand which patients benefit most and how these devices are used in real life.
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
This registry collects information about people who have cardiogenic shock, a serious condition where the heart cannot pump enough blood. Your participation may help doctors learn which treatments and monitoring best improve outcomes.
This trial is a registry that collects information about people with cardiogenic shock to better understand outcomes and improve management. It may help by contributing real-world data on what treatments and timing work best for different heart-related shock causes.
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
This study is a “registry,” meaning it collects health information from people hospitalized with cardiogenic shock. It may help doctors better understand the condition and improve care over time.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.